Myoscience Focused Cold Therapy Device Receives FDA Clearance

Written by  Anuja Vaidya | Thursday, 24 January 2013 19:26
Social sharing
Myoscience in Redwood City, Calif., a medical device company, announced that the newest generation of its patented device technology has received FDA clearance for the treatment of pain.   
Focused Cold Therapy — the patented technology — delivers cold to targeted nerves. The cold induces a hibernating state and achieves an immediate result.

The hand-held device allows for treatment of pain without systemic side effects or addictive potential.

More Articles on Pain Management:

SPR Therapeutics Raise $5M For Commercializing Pain Therapies
Study: Joint Disorders, Back Pain Among Top Reasons People Visit Physicians
Study: Vitamin D May Not Prevent Osteoarthritis

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months